400 related articles for article (PubMed ID: 11507197)
1. Effect of alpha interferon on the hepatitis C virus replicon.
Guo JT; Bichko VV; Seeger C
J Virol; 2001 Sep; 75(18):8516-23. PubMed ID: 11507197
[TBL] [Abstract][Full Text] [Related]
2. Interferon-alpha and ribavirin resistance of Huh7 cells transfected with HCV subgenomic replicon.
Aus dem Siepen M; Oniangue-Ndza C; Wiese M; Ross S; Roggendorf M; Viazov S
Virus Res; 2007 Apr; 125(1):109-13. PubMed ID: 17254660
[TBL] [Abstract][Full Text] [Related]
3. Antiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly(i)-poly(c), tumor necrosis factor alpha, and ribavirin in hepatitis C virus subgenomic replicons.
Lanford RE; Guerra B; Lee H; Averett DR; Pfeiffer B; Chavez D; Notvall L; Bigger C
J Virol; 2003 Jan; 77(2):1092-104. PubMed ID: 12502825
[TBL] [Abstract][Full Text] [Related]
4. Replication studies using genotype 1a subgenomic hepatitis C virus replicons.
Gu B; Gates AT; Isken O; Behrens SE; Sarisky RT
J Virol; 2003 May; 77(9):5352-9. PubMed ID: 12692237
[TBL] [Abstract][Full Text] [Related]
5. Antiviral action of interferon-alpha against hepatitis C virus replicon and its modulation by interferon-gamma and interleukin-8.
Jia Y; Wei L; Jiang D; Wang J; Cong X; Fei R
J Gastroenterol Hepatol; 2007 Aug; 22(8):1278-85. PubMed ID: 17565587
[TBL] [Abstract][Full Text] [Related]
6. Detection of anti-hepatitis C virus effects of interferon and ribavirin by a sensitive replicon system.
Kato T; Date T; Miyamoto M; Sugiyama M; Tanaka Y; Orito E; Ohno T; Sugihara K; Hasegawa I; Fujiwara K; Ito K; Ozasa A; Mizokami M; Wakita T
J Clin Microbiol; 2005 Nov; 43(11):5679-84. PubMed ID: 16272504
[TBL] [Abstract][Full Text] [Related]
7. [Investigating the inhibitory effects of interferon-alpha on the replication of hepatitis C virus replicon].
Jia YT; Wei L; Jiang D; Cong X; Fei R
Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(29):2065-9. PubMed ID: 16313804
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of the interferon alpha response against hepatitis C virus replicons.
Guo JT; Sohn JA; Zhu Q; Seeger C
Virology; 2004 Jul; 325(1):71-81. PubMed ID: 15231387
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity and resistance profile of samatasvir, a novel NS5A replication inhibitor of hepatitis C virus.
Bilello JP; Lallos LB; McCarville JF; La Colla M; Serra I; Chapron C; Gillum JM; Pierra C; Standring DN; Seifer M
Antimicrob Agents Chemother; 2014 Aug; 58(8):4431-42. PubMed ID: 24867983
[TBL] [Abstract][Full Text] [Related]
10. Alpha interferon induces distinct translational control programs to suppress hepatitis C virus RNA replication.
Wang C; Pflugheber J; Sumpter R; Sodora DL; Hui D; Sen GC; Gale M
J Virol; 2003 Apr; 77(7):3898-912. PubMed ID: 12634350
[TBL] [Abstract][Full Text] [Related]
11. Synergistic inhibition of intracellular hepatitis C virus replication by combination of ribavirin and interferon- alpha.
Tanabe Y; Sakamoto N; Enomoto N; Kurosaki M; Ueda E; Maekawa S; Yamashiro T; Nakagawa M; Chen CH; Kanazawa N; Kakinuma S; Watanabe M
J Infect Dis; 2004 Apr; 189(7):1129-39. PubMed ID: 15031779
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of subgenomic hepatitis C virus RNA in Huh-7 cells: ribavirin induces mutagenesis in HCV RNA.
Kanda T; Yokosuka O; Imazeki F; Tanaka M; Shino Y; Shimada H; Tomonaga T; Nomura F; Nagao K; Ochiai T; Saisho H
J Viral Hepat; 2004 Nov; 11(6):479-87. PubMed ID: 15500548
[TBL] [Abstract][Full Text] [Related]
13. Establishment of hepatitis C virus replicon cell lines possessing interferon-resistant phenotype.
Namba K; Naka K; Dansako H; Nozaki A; Ikeda M; Shiratori Y; Shimotohno K; Kato N
Biochem Biophys Res Commun; 2004 Oct; 323(1):299-309. PubMed ID: 15351737
[TBL] [Abstract][Full Text] [Related]
14. Nonstructural protein 5A does not contribute to the resistance of hepatitis C virus replication to interferon alpha in cell culture.
Aus dem Siepen M; Lohmann V; Wiese M; Ross S; Roggendorf M; Viazov S
Virology; 2005 Jun; 336(2):131-6. PubMed ID: 15892954
[TBL] [Abstract][Full Text] [Related]
15. Identification of three interferon-inducible cellular enzymes that inhibit the replication of hepatitis C virus.
Jiang D; Guo H; Xu C; Chang J; Gu B; Wang L; Block TM; Guo JT
J Virol; 2008 Feb; 82(4):1665-78. PubMed ID: 18077728
[TBL] [Abstract][Full Text] [Related]
16. Double-stranded RNA-activated protein kinase inhibits hepatitis C virus replication but may be not essential in interferon treatment.
Chang JH; Kato N; Muroyama R; Taniguchi H; Guleng B; Dharel N; Shao RX; Tateishi K; Jazag A; Kawabe T; Omata M
Liver Int; 2010 Feb; 30(2):311-8. PubMed ID: 19840259
[TBL] [Abstract][Full Text] [Related]
17. Novel alpha interferon (IFN-alpha) variant with improved inhibitory activity against hepatitis C virus genotype 1 replication compared to IFN-alpha2b therapy in a subgenomic replicon system.
Escuret V; Martin A; Durantel D; Parent R; Hantz O; Trépo C; Menguy T; Bottius E; Dardy J; Maral J; Escary JL; Zoulim F
Antimicrob Agents Chemother; 2006 Dec; 50(12):3984-91. PubMed ID: 17030563
[TBL] [Abstract][Full Text] [Related]
18. The transcriptome of HCV replicon expressing cell lines in the presence of alpha interferon.
Hayashi J; Stoyanova R; Seeger C
Virology; 2005 May; 335(2):264-75. PubMed ID: 15840525
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of subgenomic hepatitis C virus RNA replication in HeLa cells.
Kanda T; Yokosuka O; Mikata R; Zhang KY; Tanaka M; Tada M; Fukai K; Imazeki F; Saisho H
Hepatogastroenterology; 2007; 54(73):32-5. PubMed ID: 17419226
[TBL] [Abstract][Full Text] [Related]
20. Synergistic antiviral activity of human interferon combinations in the hepatitis C virus replicon system.
Larkin J; Jin L; Farmen M; Venable D; Huang Y; Tan SL; Glass JI
J Interferon Cytokine Res; 2003 May; 23(5):247-57. PubMed ID: 12804067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
